John M. Burke

Affiliations: 
Microbiology and Molecular Genetics University of Vermont, Burlington, VT, United States 
Area:
catalytic RNA molecules
Website:
http://www.uvm.edu/~uvmpr/?Page=experts/experts.php&SM=mediasub.html&ID=jburke
Google:
"John M. Burke"
Bio:

http://www.uvm.edu/~vase/members/PDF/BurkeJ.pdf

Mean distance: 8.84
 
SNBCP

Parents

Sign in to add mentor
Uttam L. RajBhandary grad student 1983 MIT
 (Structure of intervening sequences within mitochondrial genes of Neurospora crassa and the identification of an intron sequence implicated in RNA splicing)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Davids MS, O'Connor OA, Jurczak W, et al. (2021) Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies. Blood Advances
Stahlhut KN, Dowell JA, Temme AA, et al. (2021) Genetic control of arbuscular mycorrhizal colonization by Rhizophagus intraradices in Helianthus annuus (L.). Mycorrhiza
Choueiri TK, Tomczak P, Park SH, et al. (2021) Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. The New England Journal of Medicine. 385: 683-694
Hlubocky FJ, Back AL, Shanafelt TD, et al. (2021) Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task Force. Jco Oncology Practice. OP2100147
Zheng B, Wille L, Peppel K, et al. (2021) A systems pharmacology model for gene therapy in sickle cell disease. Cpt: Pharmacometrics & Systems Pharmacology
Hlubocky FJ, Shanafelt TD, Back AL, et al. (2021) Creating a Blueprint of Well-Being in Oncology: An Approach for Addressing Burnout From ASCO's Clinician Well-Being Taskforce. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 41: e339-e353
Sayama H, Marcantonio D, Nagashima T, et al. (2021) Virtual Clinical Trial Simulations for a Novel KRAS Inhibitor (ASP2453) in Non-Small Cell Lung Cancer. Cpt: Pharmacometrics & Systems Pharmacology
Madrasi K, Das R, Mohmmadabdul H, et al. (2021) Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Fowler NH, Samaniego F, Jurczak W, et al. (2021) Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2003433
Sharman JP, Brander DM, Mato AR, et al. (2021) Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial. The Lancet. Haematology
See more...